News

Statins’ Dual Effect May Extend Survival of Ankylosing Spondylitis Patients, Study Finds

Cholesterol-lowering medications called statins may lower mortality rates in patients with ankylosing spondylitis more efficiently than in the general population, new research suggests. The study, “Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study,” was published in the journal Annals of the Rheumatic Diseases (ARD).

European Commission Approves Sandoz Biosimilar Erelzi to Treat Various Inflammatory Diseases

The European Commission recently approved Erelzi, a biosimilar etanercept drug manufactured by the Sandoz division of Switzerland’s Novartis, for all therapeutic indications of its reference medicine Enbrel (etanercept), including ankylosing spondylitis. The June 27 announcement followed an extensive analytical, preclinical and clinical program focused on Erelzi, formerly known…